epirubicin Cancer Research Results
EPI, epirubicin: Click to Expand ⟱
| Features: |
Epirubicin, an anthracycline chemotherapeutic agent, has several mechanisms of action, one of which is the production of reactive oxygen species (ROS). Here are some key points regarding epirubicin and its relationship with ROS:
Mechanism of Action and ROS Generation
-Epirubicin exerts its anticancer effects primarily by intercalating into DNA and inhibiting topoisomerase II, leading to DNA strand breaks.
|
Scientific Papers found: Click to Expand⟱
| - |
in-vitro, |
Bladder, |
T24/HTB-9 |
|
|
|
ChemoSen↑, TumCCA↑, Apoptosis↑, cl‑Casp3↑, cl‑Casp9↑, BAX↑, P53↑, P21↑, Bcl-2↓, ROS↑,
Showing Research Papers: 1 to 1 of 1
* indicates research on normal cells as opposed to diseased cells
Total Research Paper Matches: 1
Pathway results for Effect on Cancer / Diseased Cells:
Redox & Oxidative Stress ⓘ
ROS↑, 1,
Cell Death ⓘ
Apoptosis↑, 1, BAX↑, 1, Bcl-2↓, 1, cl‑Casp3↑, 1, cl‑Casp9↑, 1,
DNA Damage & Repair ⓘ
P53↑, 1,
Cell Cycle & Senescence ⓘ
P21↑, 1, TumCCA↑, 1,
Drug Metabolism & Resistance ⓘ
ChemoSen↑, 1,
Total Targets: 10
Pathway results for Effect on Normal Cells:
Total Targets: 0
Query results interpretion may depend on "conditions" listed in the research papers.
Such Conditions may include :
-low or high Dose
-format for product, such as nano of lipid formations
-different cell line effects
-synergies with other products
-if effect was for normal or cancerous cells
Filter Conditions: Pro/AntiFlg:% IllCat:% CanType:% Cells:% prod#:110 Target#:% State#:% Dir#:%
wNotes=0 sortOrder:rid,rpid
Home Page